Comerica Bank Cytosorbents Corp Transaction History

Comerica Bank

$23.4 Billion
Q1 2025

A detailed history of Comerica Bank transactions in Cytosorbents Corp stock. As of the latest transaction made, Comerica Bank holds 3,307 shares of CTSO stock, worth $2,877. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,307

Previous 3,687 10.31%

Holding current value

$2,877

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.89 - $1.3 $338 - $494	-380 Reduced 10.31%	3,307 $3,000
Q4 2024 Feb 14, 2025	BUY	$0.74 - $1.35 $657 - $1,200	889 Added 31.77%	3,687 $3,000
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.55 $454 - $1,005	-649 Reduced 18.83%	2,798 $4,000
Q2 2024 Aug 15, 2024	BUY	$0.7 - $1.01 $1,826 - $2,636	2,610 Added 311.83%	3,447 $2,000
Q1 2024 May 15, 2024	BUY	$0.86 - $1.07 $273 - $340	318 Added 61.27%	837 $0
Q4 2023 Feb 14, 2024	BUY	$1.08 - $1.94 $281 - $506	261 Added 101.16%	519 $0
Q3 2023 Nov 21, 2023	BUY	$1.86 - $4.03 $479 - $1,039	258 New	258 $0

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.2M

Call Options Held

8.1K

Put Options Held

6.9K

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account